You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

QGE031

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Spontaneous Urticaria Trial (Ligelizumab)

No longer available
  • Chronic Spontaneous Urticaria
  • (no location specified)
May 6, 2022

Allergy, Peanut Trial in Worldwide (ligelizumab, Placebo)

Recruiting
  • Allergy, Peanut
  • Birmingham, Alabama
  • +50 more
Jul 29, 2022

Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab)

Completed
Has Results
  • Chronic Spontaneous Urticaria
  • Ligelizumab
  • Birmingham, Alabama
  • +66 more
Oct 7, 2021

Chronic Inducible Urticaria Trial in Worldwide (Ligelizumab, Placebo)

Terminated
  • Chronic Inducible Urticaria
  • Litchfield Park, Arizona
  • +64 more
Jan 26, 2023

Chronic Spontaneous Urticaria Trial in Worldwide (QGE031, Omalizumab, Placebo)

Completed
Has Results
  • Chronic Spontaneous Urticaria
  • QGE031
  • +2 more
  • Birmingham, Alabama
  • +81 more
Dec 9, 2020

Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab)

Terminated
  • Chronic Spontaneous Urticaria
  • Birmingham, Alabama
  • +254 more
Jan 31, 2023

Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab, Omalizumab, Placebo)

Completed
Has Results
  • Chronic Spontaneous Urticaria
  • Ligelizumab
  • +2 more
  • Gilbert, Arizona
  • +160 more
Dec 12, 2022

Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab, Omalizumab, Placebo)

Completed
  • Chronic Spontaneous Urticaria
  • Ligelizumab
  • +2 more
  • Birmingham, Alabama
  • +182 more
Aug 5, 2022

Asthma Trial in Worldwide (QGE031, Placebo)

Terminated
Has Results
  • Asthma
  • QGE031
  • Placebo
  • Birmingham, Alabama
  • +36 more
Aug 7, 2017

Atopic Dermatitis Trial in Austria, France, Germany (QGE031, Placebo, Cyclosporine A)

Completed
  • Atopic Dermatitis
  • QGE031
  • +2 more
  • Vienna, Austria
  • +3 more
Feb 20, 2017

Asthma Trial in Worldwide (QGE031)

Terminated
Has Results
  • Asthma
  • QGE031
  • Evansville, Indiana
  • +83 more
Aug 7, 2017

Asthma Trial in Worldwide (QGE031, Omalizumab, Placebo)

Completed
Has Results
  • Asthma
  • QGE031
  • +2 more
  • Fresno, California
  • +149 more
Aug 7, 2017

Bullous Pemphigoid Trial in Worldwide (QGE031, Placebo)

Terminated
Has Results
  • Bullous Pemphigoid
  • QGE031
  • Placebo
  • Iowa City, Iowa
  • +8 more
Mar 28, 2016

Allergic Asthma Trial in Canada, Sweden (QGE031, omalizumab, )

Completed
  • Allergic Asthma
  • QGE031
  • +2 more
  • Calgary, Alberta, Canada
  • +6 more
Apr 19, 2016

Allergy Trial in Sagamihara (QGE031, Placebo)

Completed
  • Allergy
  • QGE031
  • Placebo
  • Sagamihara, Kanagawa, Japan
    Novartis Investigative Site
Nov 20, 2012

Peanut Allergy Trial (QGE031, Placebo)

Withdrawn
  • Peanut Allergy
  • QGE031
  • Placebo
  • (no location specified)
Jul 20, 2012